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ABSTRACT 
This review critically evaluates the current trends of male reproductive health problems in relation to semen quality. Increasing trend in male 
reproductive disorders observed in recent years, are principally found to associate with lifestyle and environmental factors. Lifestyle-allied diseases 
could be controlled with modification in diet, living and working environment etc. This review outlines the changing trends in male reproductive 
health and highlights the alterations in semen quality, in scientific manner. Though scientific and public concern regarding the changes on male 
reproductive health has grown in past few decades but the demonstration of a geographical differences in sperm concentration, still appears to be 
controversial. The amplitude of the difference observed cannot only be explained by methodological or confounding factors, and must to some 
extent be attributed to ethnic, genetic or environmental factors. However, there are numerous reports indicating the chronologically declining 
sperm count and standard semen parameters in various population indicating the increasing trend of male reproductive health disorders. 
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INTRODUCTION 
Reproductive health is the basic human right which refers a state of 
complete physical, social and mental well-being and not merely the 
absence of disease and infirmity in all matters relating to the 
reproductive system and to its functions and processes.[1] But 
during the past two decades, a number of reports have appeared 
which have raised serious concerns about the development of 
reproductive problems in animals and man. There are numerous 
reports of alligators with abnormal male genital development[2] and 
of reproductive changes in fish and birds.[3] Simultaneously, there 
have been controversial reports of alterations in human semen 
quality (i.e. changes in semen volume, sperm concentration, sperm 
motility and sperm morphology)[4], along with reports of an 
emerging incidence of congenital malformations of the male 
reproductive tract, such as cryptorchidism and hypospadias[5], and 
of an increasing trend of testicular cancer[6]. However, there is 
controversy over whether or not these reported changes in male 
reproductive health are genuine[7], and if so, what the causes and 
implications are, in particular the implications for clinicians caring 
for couples with infertility. 
Testicular cancer 
Even though a lot of the changes observed in male reproductive 
health are controversial, there seems little disagreement that 
testicular cancer is increasing in rate of recurrence (Fig 1A), with 
unexplained increase in the age-standardized incidence observed in 
Europe (Fig 1B)[8] and the USA[9]. In the west of Scotland, the 
number of testicular germ cell tumours registered has more than 
doubled over 1990 than it was in 1960[10], while a study from 
Norway reported that the age-related frequency of testicular cancer 
increased from 2.7 per 1 lakh individuals in 1955 to 8.5 per 1 lakh 
individuals in 1992.6 A similar study reported 61% increase in 
testicular cancer in southern Norway from 1986-87 to 1991-92.6 In 
the USA, the overall age-related incidence of testicular and germ cell 
cancer has increased 3.5-fold during the past 60 years (Fig 2).9 There 
is considerable geographical variation in both the occurrence of 
testicular cancer and in the observed rate of its growth[11]. This 
geographical variation may be linked with that observed in semen 
quality - testicular cancer is four times more common in Denmark, 
where studies have shown low sperm concentrations in men[12], 




and colleagues[8] evaluated data from Denmark, Norway, Sweden, 
the former German Democratic Republic, Finland and Poland, 
including data on over 30,000 cases of testicular cancer from 1945 
to 1989 in men aged 20-84. They reported considerable regional 
variation in both the incidence of testicular cancer and in the 
observed rate of increase, ranging from a 2.3% increase per annum 
in Sweden to 5.2% per annum in the former East Germany. Similarly, 
Zheng et al.9 concluded that the increase in testicular cancer 
observed in men born after 1910 in USA was enlightened mainly by 
a strong birth cohort effect. However, from some other studies it is 
now clear that men with a history of cryptorchidism, inguinal hernia, 
hypospadias and hydrocele have a significantly increased risk of 
testicular cancer.[14] It has been suggested that paternal occupation 
before conception may alter the testicular cancer risk of 
offspring[15], as may the parental use of pesticides or fertilizers[16] 
or childhood residence in areas with a high nitrate concentration in 
ground water[17]. While fathers of testicular cancer patients have 
been found to have a slight increase in their own risk of the disease, 
a much more significant risk attaches to the brothers of men with 
testicular cancer.[18] These latter observations support the possible 
involvement of a genetic component in the aetiology of testicular 
cancer. In a case control study in the UK, Davies et al.[19] found that, 
while cryptorchidism was a major risk factor for testicular cancer, 
each extra quarter pint of milk consumed amplified the risk by 1.39-
fold. 
Congenital reproductive tract defects in male 
The incidence of congenital malformation of the male genital tract is 
also changing its pattern, with increase in the prevalence of 
cryptorchidism and hypospadias[20]. Cryptorchidism has increased 
by as much as 65-77% over recent decades in the UK5, while USA 
data have shown that rates of cryptorchidism have not changed[21], 
although a large study from the USA reported that rates of 
hypospadias have doubled between the 1970s and 1980s[22]. In one 
Kallen et al.[23] who conducted a multicentre study of 8,122 boys 
from seven malformation surveillance systems around the world, 
resolved that a true geographical variation exists in the prevalence 
of hypospadias at birth. Berkowitz et al.[24] who were considering 
at the risk factors for cryptorchidism, suggested that                       
maternal obesity, low birth weight, the presence of other congenital  
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malformations, ethnic group and a family history may be relevant. 
Others have  
suggested strong associations between cryptorchidism and low 
social class[25]. 
Altering semen quality 
Classical reports 
The proposition that semen quality is changing is not new. In 1974, 
Nelson and Bunge[26] reported data on 386 men presenting for 
vasectomy in the USA. The mean sperm concentration of this group 
was 48×106/ml, only 7% of them were reported to have sperm 
concentrations above 100×106/ml which is far below than the 
concentrations reported in the earlier studies of 120×106/ml[27], 
145×106/ml[28] and 100.7×106/ml[29] respectively. In 1951, 
MacLeod and Gold[30] had published their landmark study of semen 
quality in 1,000 male partners in infertile relationships, together 
with a similar number of men of proven fertility and reported an 
average sperm concentration of 107×106/ml, with 5% of them 
having sperm concentrations under 20×106/ml, and 44% having 
above 100×106/ml. Nelson and Bunge26 speculated that their data 
‘would tend to incriminate an environmental factor to which the 
entire population has been exposed’26. Later, several reports of 
semen quality in fertile men found intermediate values for average 
sperm concentration of 70×106 - 81×106/ml[31]. Then MacLeod and 
Wang[32] who investigated infertile marriages reported that there 
was no evidence of a general drop in semen quality. Leto and 
Frensilli[33] reported a decline in semen quality amongst potential 
semen donors. In 1980, James[34] reported the first review of 
published data on semen quality in men of proven fertility and in 
unselected normal men. Bostofte et al.[35] compared 1,077 Danish 
men presenting for evaluation of infertility in 1952 with 1,000 
similar men presenting 20 years later in 1972. They observed a 
significant drop in sperm concentration, a decrease in sperm 
motility and an increase in the proportion of abnormal spermatozoa. 
Similar findings were reported in a Swedish study in 1960-61.[36] 
These early publications failed to raise major public health concerns, 
perhaps because the data came from selected groups of men, 
unrepresentative of the general population, including men attending 
infertility clinics[36] or semen donors[33,37].  
Jensen et al.[12] in 1992 reawakened concern over the possibility of 
secular trends in semen quality, publishing a meta-analysis of data 
on semen quality published since 1930 in normal men. Data were 
obtained on 14,947 men, published in 61 papers during 1938-1990. 
Using linear regression, they observed a decline in average semen 
volume from 3.40 ml in 1940 to 2.75 ml in 1990. A similar analysis 
for sperm concentration suggested an apparent decline from 
113×106/ml in 1940 to 66×106/ml in 1990. There was no change in 
the average age of the men studied, and no apparent influence of age 
on the observed secular trend in semen quality. Predictably, the 
central message of this meta-analysis, that sperm counts had 
declined by about 50% over the past 50 years, attracted enormous 
attention and generated much controversy[38,39]. Bromwich and 
colleagues38 later speculated that much of the apparent change in 
semen quality could be accounted for by a change in the ‘accepted’ 
definition of the lower limits of ‘normal’ semen from around 
60×106/ml in the 1920s[40] to 20×106/ml, which is the figure 
commonly accepted today [41]. However, it has been pointed out 
that at least some of the earlier papers did include men with semen 
quality in this range[42]. Keiding and Skakkebaek [43] then pointed 
out, all of the statistical models agree on one qualitative message - a 
decline in semen quality over time. However, it is surely legitimate 
that all the available data, as presented, even if imperfect, help to 
define questions and priorities for future study. 
Recent reports 
Most of the reports that appeared closely after the meta-analysis of 
Jensen et al.12 provided alternative interpretations of the data. 
Unfortunately, the available data still fail to reach a definite 
conclusion as to whether or not there is any secular trend in semen 
quality. Auger et al.[44] published data on semen quality in fertile 
Parisian men by examining 1,750 fertile men with consistent 
methods of subject recruitment and laboratory technique, during a 
20 year period. They observed a fall in all of the classical measures 
of semen quality over time. Sperm count was found to be affected by 
age with each year of advancing age being associated with a 3.3% 
fall in sperm concentration. An accompanying editorial by 
Sherins[45] unfortunately misinterpreted this study as being 
concerned with men selected as sperm donors, rather than potential 
donors, and thus raised concerns about selection bias that were not 
well founded. Numerous other groups have published data 
proposing a secular trend in semen quality amongst normal men. 
Irvine et al.4 later observed that the median sperm concentration fell 
from 98×106/ml among donors born before 1959 in Scotland to 
78×106/ml amongst donors born after 1970. In a similar study, Van 
Waeleghem et al.[46] observed declines in sperm concentration 
from a mean of 71×106/ml to 58.6×106/ml in sperm donors of 
Belgium. 
In contrast, a number of reports have failed to find any evidence of a 
secular trend in semen quality. In a study of 302 volunteer semen 
donors in Toulouse, France, between 1977 and 1992 no evidence of 
changes in semen quality with time was observed[47]. 
Handelsman[48] also found no evidence of any effect of year of 
observation or year of birth on sperm concentration, total sperm 
number or ejaculate volume. Later two significant reports from the 
USA have provided evidence of unchanging semen quality in the 
populations studied of Fisch et al.[49] and Paulsen et al.[50] De 
Mouzon et al.[51] have published the largest retrospective review of 
semen quality data. On the basis of the French national in vitro 
fertilization (IVF) register, they reviewed the results of 19,848 
semen analyses from 7,714 men undergoing IVF for tubal disease, 
and having a normal semen analysis prior to IVF. They found a 
significant decrease in semen quality with later year of birth, the 
average sperm concentration in men born before 1939 being 
92.5×106/ml, falling to 77.1×106/ml for men born after 1965. In a 
smaller study, Berling & Wölner-Hanssen[52] reported on semen 
quality in 718 semen samples submitted by infertile men from 1985 
to 1995 in one Swedish centre and found no relationships with age 
or date of birth, although ejaculate volume seemed to decrease and 
normal morphology, motility and sperm penetration of hyaluronic 
acid polymer increased during the study period. 
Most recently, a very careful reanalysis of the historical data[12] on 
semen quality in normal men has been published[53]. These 
workers used multiple linear regression models, controlling for 
abstinence time, age, the proportion of the sample with proven 
fertility, specimen collection method, study goal and geographical 
location to examine regional differences and the interaction between 
region and year of publication. Using a linear model, they found that 
sperm concentrations and the rate of decline in sperm concentration 
differed significantly across regions. They concluded that there was 
evidence of a decline in sperm concentrations in the USA of 
1.5×106/ml per year, and in Europe of 3.13×106/ml per year, but not 
in non-Western countries. Results were similar when other (non-
linear) models were used, and these workers concluded that their 
results were unlikely to be due to either confounding or selection 
bias53. Thus, the available literature on secular changes in semen 
quality is, at best, inconclusive. To a greater or lesser extent, all of 
the available data suffer from the problems of being retrospective, 
collected in different countries, at different times, using different 
methods of subject selection and recruitment and different 
laboratory methodology. The retrospective nature of the data means 
that control of important confounding variables is often imperfect, 
weakening the conclusions reached. More evidence is clearly 
needed, yet one is tempted to wonder whether the inherent 
difficulties in laboratory methodology, subject selection and the 
large number of potential confounding variables involved mean that 
it may never be possible to resolve the issue of secular trends in 
human semen quality with certainty. 
Regional variations 
Although the position with regard to secular changes in semen 
quality remains unclear, an important observation to emerge from 
this work is the striking regional differences that are apparent: for 
example, the above mentioned study by Fisch et al.49, in which sperm 
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concentrations were highest in New York (131.5×106/ml), 
intermediate in Minnesota (100.8×106/ml), and lowest in California 
(72.7×106/ml). The Seattle data, with a geometric mean of 
46.5×106/ml, is not directly comparable50. Within Europe, similar 
patterns can be observed. Semen quality in normal Finnish men 
would appear to be high, with a mean sperm concentration of 
133.9×106/ml being reported13, whereas in Paris and Edinburgh 
lower mean values of 98.8×106/ml and 104.5×106/ml have been 
reported 4,44. In contrast, semen quality in normal men in Belgium 
has been reported at 66.8×106/ml, and in Denmark at 69.2×106/ml 
12,46. Whether or not there are also regional differences in the 
occurrence or otherwise of secular changes in semen quality is 
unknown47, but it is evident that geography is a vital confounding 
variable which should be considered when examining such data[54]. 
One study reported deteriorating semen quality in a group of 
patients resident within the area of one water supply company, but 
no change in the semen of similar patients living nearby[55]. Data 
from the Centres d’Étude et de Conservation des Oeufs et des 
Spermes Humaines (CECOS)[56] has provided strong support for the 
existence of regional differences within France, and the recent meta-
analysis by Swan et al.53 noted that intraregional differences were at 
least as large as the mean decline in sperm concentration. It is 
possible that these regional differences, which might be due to 
ethnic, environmental or lifestyle factors, could provide a valuable 
tool in addressing the hypothetical causes of changes in semen 
quality4. Using time taken to achieve a pregnancy in fertile couples 
as a measure of fertility[57], Joffe[58] examined antenatal 
population and cross-sectional studies in Finland and the UK. In both 
comparisons, fertility was significantly greater in Finland than the 
UK. The author therefore concluded that ‘the previously reported 
difference in sperm counts between Finland and elsewhere in north-
west Europe (including Great Britain) is probably not 
artefactual’[57,58]. This along with some other reports suggest that 
the reported worldwide decline in semen quality is also real (Table 
1). 
Factors contributing reproductive health disorders and altering 
semen quality 
The cause of these observed changes in male reproductive health 
remains unidentified. It is clear that lifestyle factors such as 
occupation[72], smoking[73], dress habits[74] and even time spent 
commuting[72] may be relevant. However, the hypothesis that has 
attracted most attention concerns exposure to environmental xeno-
oestrogens during development[75]. This is now a large and 
complex field, reviewed recently by the Danish EPA (Danish 
Environmental Protection Agency)[76]. Sertoli cells play an 
important role in regulating the environment within the 
seminiferous tubules, each Sertoli cell supporting the development 
of a limited number of germ cells[77]. Any perturbation in the 
development of the reproductive system that leads to a reduction in 
Sertoli cell number will reduce the individual’s ultimate capacity for 
sperm production in adult life. In most mammals, Sertoli cell 
replication occurs during foetal and postnatal life, Sertoli cell 
number becoming fixed at some stage of development. In the rat, 
Sertoli cell multiplication commences around 19-20 days of 
gestation and ceases around 15 days of postnatal life[78]. In some 
primates there is a rapid and substantial proliferation of Sertoli cells 
at the onset of puberty[79]. In man, the total number of Sertoli cells 
increases significantly between late foetal and pre-pubertal life, with 
a further increase during puberty[80]. Hence any ‘window’ for 
adverse effects on Sertoli cell multiplication may be longer in 
humans than in other species. The idea that exposure to ‘oestrogens’ 
may affect male reproductive development is founded on the 
observation that follicle-stimulating hormone (FSH) is involved in 
determining Sertoli cell number[81] and that oestrogens produced 
by Sertoli cells may keep FSH levels in check by negative feedback 
whilst Sertoli cell number is being determined. Hence, short-term 
exposure of neonatal rats to oestradiol results in a suppression of 
FSH levels and in consequence reductions in testicular weight and 
spermatogenesis in adult life, whilst exposure of rodents in utero to 
the synthetic oestrogen diethylstilboestrol (DES) results not only in 
reductions in testis size and spermatogenesis in adult life, but also in 
an increased incidence of cryptorchidism and hypospadias[82]. In a 
similar way, the male offspring of women exposed to 
diethylstilboestrol during pregnancy have an increased incidence of 
cryptorchidism and hypospadias at birth, and of abnormal 
spermatogenesis in adult life[83]. It is not clear whether they are 
any less fertile as a result[84]. The effect on testicular descent, and 
perhaps also on increase in testis cancer risk, would presumably be 
mediated through interference with the secretion of müllerian 
inhibiting substance (MIS)[85]. Testicular cancer may also be a 
congenital condition that becomes manifest at or after puberty[86]. 
Thus, the understanding of the development of the male 
reproductive system leads to the conclusion that exposure to 
exogenous oestrogens may perturb it in such a way as to give rise to 
the changes which appear to be emerging in human health. There is 
certainly concern over the growing number of chemicals that may be 
viewed as ‘endocrine disrupters’. The Danish EPA has recently 
released a report raising concern over environmental chemicals 
with oestrogenic effects76, whilst recent commentaries in the 
Lancet[87] and British Medical Journal[88] have highlighted the need 
for further research in this complex area. It is clear that there are 
chemicals in the environment which are ‘oestrogenic’, and which can 
perturb sexual development in exposed animals[89]. In mammals, it 
has been shown that exposure of pregnant mice to ethinyloestradiol 
increases the frequency of gonadal dysgenesis, cryptorchidism and 
testicular cancer, in association with impaired Leydig cell 
development and reduced Sertoli cell numbers[90] Gestational 
exposure of rats to xeno-oestrogens has been shown to result in 
reduced testicular size and sperm production[91] and we now know 
that exposure of pregnant sheep to xeno-oestrogens supresses foetal 
FSH. In an attempt to estimate the familial and genetic contributions 
to variation in human testicular function, Handelsman[92] has 
studied 11 pairs of monozygotic and 6 pairs of dizygotic twins, and 
observed that sperm concentration, testicular size and sex hormone 
binding globulin (SHBG) all had a strong familial effect, but was 
unable to confirm any genetic component. 
CONCLUSIONS 
Although the ‘environmental oestrogen’ hypothesis has attracted 
much attention, and there exist some biological data to confirm its 
plausibility, evidence that it is causally related to changes in human 
male reproductive health remains circumstantial. The evidence for 
secular changes in semen quality and other changes in male 
reproductive health is indecisive, with the exception of testicular 
cancer, though evidence for regional differences in male 
reproductive health would appear to be stronger. In both cases, 
association does not imply causality, and several other possible 
explanations require to be considered. As far as semen quality is 
concerned, sperm count is a poor index of fertility, and there are as 
yet, no data on secular changes or regional differences in sperm 
function, although there may be some evidence of regional 
differences in fertility. While the available evidence is inconclusive 
and circumstantial, its weight is considerable and at the very least it 
should raise concerns that deserve to be addressed by properly 
designed, coordinated and funded research. Delay may compromise 
the fertility and reproductive health of future generations [4,88]. 
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